Hunt for AIDS cure accelerates as GSK and U.S. experts link up

LONDON, May 11 (Reuters) - Britain's GlaxoSmithKline , which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.